【上海医药(02607.HK)公布中期业绩 归母净利为约44.59亿元 同比增长51.56%】智通财经APP讯，上海医药(02607.HK)公布2025年中期业绩，营业收入约1415.93亿元，同比增长1.56%;归属于上市公司股东的净利润约44.59亿元，同比增长51.56%;基本每股收益1.2元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.